gout	is a	crystal arthropathy
monosodium urate crystals	deposit in	joints
serum uric acid	elevated in	gout
hyperuricemia	predisposes to	gout
tophi	form in	chronic gout
CPPD deposition disease	is a	crystal arthropathy
calcium pyrophosphate crystals	deposit in	joints
pseudogout	is a	crystal arthropathy
CPPD crystals	cause	pseudogout
gout	treated with	NSAIDs
acute gout	treated with	colchicine
acute gout	treated with	corticosteroids
acute gout	treated with	NSAIDs
urate-lowering therapy	includes	allopurinol
urate-lowering therapy	includes	febuxostat
allopurinol	is a	xanthine oxidase inhibitor
febuxostat	is a	xanthine oxidase inhibitor
probenecid	increases	uric acid excretion
uric acid	decreased by	allopurinol
lesinurad	is a	URAT1 inhibitor
uric acid excretion	occurs in	kidneys
monosodium urate crystals	detected by	polarized light microscopy
synovial fluid analysis	confirms	gout
uric acid nephrolithiasis	causes	kidney stones
diuretic therapy	increases	serum uric acid
thiazide diuretics	increase	serum uric acid
loop diuretics	increase	serum uric acid
alcohol	increases	uric acid
obesity	increases	gout risk
metabolic syndrome	associated with	hyperuricemia
CKD	reduces	urate excretion
dehydration	precipitates	gout attack
dietary purines	influence	uric acid production
low-purine diet	reduces	gout risk
hydration	prevents	uric acid crystallization
tophi	indicate	chronic gout
tophi	may cause	skin ulceration
CPPD deposition disease	diagnosed by	synovial fluid analysis
CPPD crystals	appear as	rhomboid crystals
CPPD crystals	show	birefringence
MSU crystals	appear as	needle-shaped crystals
MSU crystals	show	negative birefringence
calcium pyrophosphate deposition	seen as	chondrocalcinosis
chondrocalcinosis	seen in	CPPD deposition disease
imaging	helps diagnose	crystal arthropathies
radiography	detects	chondrocalcinosis
ultrasound	detects	crystal deposits
dual-energy CT	detects	MSU crystals
gout	increases	disability
podagra	is a	gout manifestation
uric acid stones	form in	acidic urine
acidic urine	promotes	uric acid stone formation
uric acid	excreted by	kidney
gout	associated with	cardiovascular disease
CPPD deposition disease	associated with	knee osteoarthritis
OA	common in	elderly
dietary purines	influence	uric acid production
uric acid production	reduced by	allopurinol
allopurinol	can cause	hypersensitivity
colchicine	used for	gout prophylaxis
colchicine	reduces	neutrophil activation
NSAIDs	relieve	gout pain
corticosteroids	relieve	gout pain
gout	has	acute flares
acute gout	presents with	joint pain
big toe	site of	gout presentation
CPPD deposition disease	often affects	knees
knee joints	show	calcification
pseudogout	presents with	acute swelling
gout	diagnosed by	crystal analysis
crystal analysis	uses	polarized light microscopy
crystal deposits	indicate	crystal arthropathy
radiography	shows	chondrocalcinosis
pseudogout	diagnosed by	synovial fluid analysis
synovial fluid analysis	shows	crystals
crystal deposits	are	diagnostic material
gout	commonly affects	big toe
urate-lowering therapy	aims to	reduce urate levels
urate levels	are targets of	urate-lowering therapy
gout	progression to	chronic arthritis
arthritis	affects	joints
cartilage calcification	observed in	CPPD deposition disease
rheumatology	manages	crystal arthropathies
gout	increases	mortality risk
hydration	reduces	gout attack risk
diuretics	exacerbate	gout attacks
colchicine	is used for	gout prophylaxis
colchicine	used for	gout prophylaxis
febuxostat	may cause	liver enzyme elevation
allopurinol	requires	renal dose adjustment
uric acid	normalizes after	urate-lowering therapy
cartilage calcification	observed in	CPPD deposition disease
dual-energy CT	differentiates	MSU crystals from CPPD crystals
MSU crystals	are	negatively birefringent
CPPD crystals	are	rhomboid
OA	coexists with	CPPD deposition disease
gout	risk factor for	cardiovascular disease
gout	increases	disability
gout	common in	older adults
uric acid stones	linked with	dehydration
hydration	reduces	gout risk
diuretics	exacerbate	gout attacks
podagra	signals	toe gout
arthritis	can develop	chronic gout
genetics	influence	gout risk
gout	treatment goals	urate normalization
uric acid	crystallizes in	joints
uric acid	precipitates	crystal formation
tophi	correlate with	disease duration
urate-lowering therapy	requires	adherence
adherence	influences	gout control
urate-lowering therapy	is	long-term strategy
recurrent gout attacks	lead to	joint damage
MSU crystals	cause	acute inflammation
CPPD deposition disease	can cause	joint stiffness
immune response	mediates	gout inflammation
neutrophils	recruited by	MSU crystals
cytokines	mediate	gout inflammation
patients	with	gout	have
